Taro Annual Report on Form 20-F Available For Fiscal Year Ended March 31, 2023
30 Junio 2023 - 8:00AM
Business Wire
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro”)
announced that its Annual Report on Form 20-F for the fiscal year
ended March 31, 2023, filed with the Securities and Exchange
Commission (the “SEC”), is available within the Investor Relations
section of Taro’s website at www.taro.com.
Hard copies of the report may be ordered free of charge by
sending requests to:
Taro Pharmaceuticals U.S.A., Inc. 3 Skyline Drive Hawthorne, NY
10532 Attn.: William J. Coote or via email to
William.Coote@taro.com
Additionally, the report may be accessed on the SEC’s website at
www.sec.gov.
****
Taro Pharmaceutical Industries Ltd. is a multinational,
science-based pharmaceutical company, dedicated to meeting the
needs of its customers through the discovery, development,
manufacturing and marketing of the highest quality healthcare
products. For further information on Taro Pharmaceutical Industries
Ltd., please visit Taro’s website at www.taro.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230630387986/en/
William J. Coote VP, CFO (914) 345-9001
William.Coote@taro.com
Taro Pharmaceutical Indu... (NYSE:TARO)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Taro Pharmaceutical Indu... (NYSE:TARO)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
